Cargando…
Response to stereotactic ablative radiotherapy in a novel orthotopic model of non-small cell lung cancer
Stereotactic ablative radiotherapy (SABR) is the main treatment for inoperable early-stage non-small cell lung cancer (NSCLC). Despite the widespread use of SABR, the biological determinants of response to SABR remain poorly investigated. We developed an orthotopic NSCLC animal model to study the re...
Autores principales: | Oweida, Ayman, Sabri, Siham, Al-Rabea, Areej, Ebrahimi, Mojgan, Ruo, Russel, Fraser, Richard, Seuntjens, Jan, Abdulkarim, Bassam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788587/ https://www.ncbi.nlm.nih.gov/pubmed/29416719 http://dx.doi.org/10.18632/oncotarget.22727 |
Ejemplares similares
-
Advances in Radiobiology of Stereotactic Ablative Radiotherapy
por: Qiu, Bin, et al.
Publicado: (2020) -
Validation of an orthotopic non-small cell lung cancer mouse model, with left or right tumor growths, to use in conformal radiotherapy studies
por: Wang, Li Ming, et al.
Publicado: (2023) -
SABR-BRIDGE: Stereotactic ABlative Radiotherapy Before Resection to AvoId Delay for Early-Stage LunG Cancer or OligomEts During the COVID-19 Pandemic
por: Kidane, Biniam, et al.
Publicado: (2020) -
The Confluence of Stereotactic Ablative Radiotherapy and Tumor Immunology
por: Finkelstein, Steven Eric, et al.
Publicado: (2011) -
Stereotactic Ablative Radiotherapy for Oligometastatic Disease in Liver
por: Kim, Myungsoo, et al.
Publicado: (2014)